- ￥2260
- LSM Bio
- 进口
- PAab09882
- 2025年07月08日
- ELISA, WB
- E. coli - derived recombinant protein
- Human
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原：
Recombinant Protein
- 亚型：
IgG
- 形态：
liquid
- 保存条件：
负20摄氏度
- 克隆性：
polyclonal
- 标记物：
Non-conjugated
- 适应物种：
Human
- 保质期：
6个月
- 抗原来源：
Goat
- 目录编号：
Q9BZJ3
- 级别：
纯化级别
- 库存：
50
- 供应商：
LSM bio
- 宿主：
E. coli - derived recombinant protein
- 应用范围：
ELISA, WB
- 浓度：
≥95% as determined by SDS-PAGE
- 靶点：
Recombinant Protein
- 抗体英文名：
IgG control antibody
- 抗体名：
IgG control antibody
- 规格：
100μl
IgG control antibody
Product Name IgG control antibody
Catalog No PAab09882
Packing 100ul
Form liquid
Alternative Name Human IgG
Purification Immunogen affinity purified
Purity 95% as determined by SDS-PAGE
Host Goat
Isotype IgG
Storage PBS with 0.02% sodium azide and 50% glycerol pH 7.3 , -20Centigrade for 24 months (Avoid repeated freeze / thaw cycles.)
Background/ FUNCTION
Immunogen Recombinant Protein
Specificity Human
Tested Application ELISA, WB
Recommended dilution WB: 1:2000-1:20000
IHC use
WB use
human plasma tissue were subjected to SDS PAGE followed by western blot with PAab09882( Human IgG antibody) at dilution of 1:5000
Protein Information
Gene ID
Uniprot ID
Calculated MW 22 kDa
Research Area Immunology
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Bispecific Antibody Derivatives Based on Full-Length IgG Formats
improvements were made in protein engineering during the last years. This allows the design of several new IgG-based bispecific antibody formats that can be prepared in high yields and high homogeneity using conventional expression and purification techniques
in the development of BsAb has been the difficulty of producing the materials in sufficient quality and quantity by traditional technologies such as the hybrid hybridoma and chemical conjugation methods. The development of IgG-like BsAbs as therapeutic agents
of the constructs (or formats) and production efficiency. Here we describe a recombinant method for the construction and production of a tetravalent IgG-like BsAb molecule, IgG–scFv fusion, in which, a single-chain Fv (scFv) antibody fragment of one antigen
技术资料暂无技术资料 索取技术资料
